Elsevier

Cytokine

Volume 50, Issue 2, May 2010, Pages 152-157
Cytokine

Sputum biomarker profiles in cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) and association between pulmonary function

https://doi.org/10.1016/j.cyto.2010.02.004Get rights and content

Abstract

Lung diseases like cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) are associated with chronic airway inflammation. The aim of our study was to compare a complex biomarker profile in order to characterize specific inflammatory patterns in sputum of patients with CF and COPD. Induced sputum samples of 19 CF-, 26 COPD patients and 21 healthy controls were analyzed for concentrations of IL-1β, IL-2, IL-6, IL-8, IL-13, IP-10, MCP-1, IFN-γ and TNF-α using the new cytometric bead array (CBA) technology. Significant differences in airway biomarker profiles of CF and COPD were detected. Patients with CF showed a significant increase in IL-1β, IL-6, IL-8, IL-13, TNF-α, IFN-γ and MCP-1. COPD patients showed an increase in IL-6, IL-8, IL-13 and MCP-1 compared to healthy controls. CF and COPD compared to each other exhibited differences in IL-1β, IL-2, IL-8, TNF-α, IFN-γ and MCP-1 levels. Significant correlations between the parameters of lung function and sputum biomarker levels were found. Analyzing induced sputum allows characterization of specific airway biomarker profiles in CF and COPD and can be related to the clinical status of the patient. CBA of induced sputum seems to be a pivotal tool to characterize pulmonary inflammation.

Introduction

Cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) are chronic airway diseases [1], [2] with different causes that share some features in pathologic changes and clinical presentation. In these diseases, there are chronic mucosal and airway inflammation, each with distinct pathophysiologic features, but a common increase in the infiltration of neutrophils [3] in addition to a variety of inflammatory mediators [4]. The pathologic processes in these diseases seem to involve progressive inflammatory responses with elements of tissue remodeling [5], airway obstruction and reduction in expiratory flow rates [6].

In COPD, an abnormal inflammatory response of the lung to noxious particles or gases is present [7]. Although cigarette smoking is the main pathological driver of COPD [8], [9], other factors may be involved. Genetic predisposition could explain why only a proportion of cigarette smokers develop COPD [10]. Other factors include particulates in environmental pollution and exposure to biomass combustion, which may explain why some patients who develop COPD are never-smokers [11].

In CF, the inflammatory response is driven mainly by bacterial infections, especially Pseudomonas species, which leads to tissue breakdown and severe lung damage [12]. Markers of inflammatory activity play an important role for assessment and management of those respiratory diseases [13]. Due to technical reasons, previous investigations of sputum in chronic lung diseases, like CF and COPD, focused on cytology and determination of single inflammatory mediators [14], [15], [16].

The determination of cytokines and chemokines in induced sputum by cytometric bead array (CBA) promises to be of substantial benefit for sputum investigations because numerous analytes can be measured simultaneously with a small sample volume [17]. In addition to this, CBA is faster and more cost effective than ELISA technology.

In our study, CBA was used to determine sputum levels of pro-inflammatory cytokines and chemokines (IL-1β, IL-2, IL-6, IL-8, IL-13, IP-10, INF-γ, MCP-1 and TNF-α) in induced sputum of patients with CF and COPD in comparison to healthy control subjects. We hypothesized, that the analysis of these different pleiotropic inflammatory mediators may lead to pathognomonic patterns for the underlying disease. Furthermore, it was postulated that these patterns of biomarkers show a significant correlation to the clinical status (lung function) of our patients.

Section snippets

Subjects and selection

Patients were recruited from the Division of Pediatric Pulmonology, Allergy and Cystic fibrosis, Johann Wolfgang Goethe-University Hospital, Frankfurt, Germany and the Department of Internal Medicine, Johannes Gutenberg-University Hospital, Mainz, Germany. The population of this study consisted of 19 clinically stable patients with cystic fibrosis (18 were Pseudomonas aeruginosa-infected), 26 clinically stable patients with COPD and 21 non-smoking healthy control subjects. Clinical stability

Results

All nine biomarkers were detectable in nearly every sputum sample derived from patients with CF and COPD and compared to healthy control subjects. However, looking at IP-10, MCP-1, IL-2, IFN-γ and IL-13 some sputum samples were under the limit of detection. Measured parameters were grouped in neutrophilic inflammatory cytokines (Fig. 1A: IL-1β, IL-6 and TNF-α), chemokines (Fig. 1B: IL-8, IP-10 and MCP-1) and TH1/TH2 -cytokines (Fig. 1C: IL-2, IFN-γ and IL-13).

The inflammatory

Discussion

Markers of inflammatory activity are important for the assessment and management of chronic respiratory diseases like CF and COPD [21]. In order to study the local inflammatory response non-invasively, we employed a standardized and validated sputum-induction protocol [18]. Numerous studies have analyzed inflammatory cytokines in sputum, in relation to clinical status [22], [23], [24], [25]. The new CBA technique allows characterization of specific airway biomarker profiles from small sputum

References (46)

  • S. Schmitt-Grohe et al.

    Interleukin-8 in whole blood and clinical status in cystic fibrosis

    Cytokine

    (2005)
  • M. Romano et al.

    Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment

    Immunity

    (1997)
  • C. Brightling et al.

    Targeting TNF-alpha: a novel therapeutic approach for asthma

    J Allergy Clin Immunol

    (2008)
  • C.A. Dinarello

    Biologic basis for interleukin-1 in disease

    Blood

    (1996)
  • D. Hartl et al.

    Pulmonary T(H)2 response in Pseudomonas aeruginosa-infected patients with cystic fibrosis

    J Allergy Clin Immunol

    (2006)
  • M. Kelly et al.

    Modulating leukocyte recruitment in inflammation

    J Allergy Clin Immunol

    (2007)
  • A. Elizur et al.

    Airway inflammation in cystic fibrosis

    Chest

    (2008)
  • M.W. Konstan et al.

    Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation

    Am J Respir Crit Care Med

    (1994)
  • S.A. Kharitonov et al.

    Biomarkers of some pulmonary diseases in exhaled breath

    Biomarkers

    (2002)
  • D. Knight

    Epithelium–fibroblast interactions in response to airway inflammation

    Immunol Cell Biol

    (2001)
  • R. Dhand

    Ventilator graphics and respiratory mechanics in the patient with obstructive lung disease

    Respir Care

    (2005)
  • S. Murin et al.

    Cigaret smoking and the lung

    Clin Rev Allergy Immunol

    (1997)
  • P. Montnemery et al.

    Familial related risk-factors in the development of chronic bronchitis/emphysema as compared to asthma assessed in a postal survey

    Eur J Epidemiol

    (2000)
  • Cited by (109)

    View all citing articles on Scopus
    View full text